These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33449835)

  • 1. Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database.
    Taha MK; Weil-Olivier C; Bouée S; Emery C; Nachbaur G; Pribil C; Loncle-Provot V
    Hum Vaccin Immunother; 2021 Jun; 17(6):1858-1866. PubMed ID: 33449835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database.
    Weil-Olivier C; Taha MK; Bouée S; Emery C; Loncle-Provot V; Nachbaur G; Beck E; Pribil C
    Hum Vaccin Immunother; 2022 Dec; 18(1):2021764. PubMed ID: 35192785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006-2015.
    Parent du Chatelet I; Deghmane AE; Antona D; Hong E; Fonteneau L; Taha MK; Lévy-Bruhl D
    J Infect; 2017 Jun; 74(6):564-574. PubMed ID: 28279715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 - a secondary database analysis.
    Guedes S; Bricout H; Langevin E; Tong S; Bertrand-Gerentes I
    BMC Public Health; 2022 Mar; 22(1):521. PubMed ID: 35296287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity Increases the Risk of Invasive Meningococcal Disease in Adults.
    Lundbo LF; Harboe ZB; Sandholdt H; Smith-Hansen L; Valentiner-Branth P; Hoffmann S; Benfield T
    Clin Infect Dis; 2022 Aug; 75(1):125-130. PubMed ID: 34569601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease.
    Taha MK; Martinon-Torres F; Köllges R; Bonanni P; Safadi MAP; Booy R; Smith V; Garcia S; Bekkat-Berkani R; Abitbol V
    Expert Rev Vaccines; 2022 May; 21(5):659-674. PubMed ID: 35271781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Mortality and State Financial Support in Invasive Meningococcal Disease-Real-World Data Analysis Using the French National Claims Database (SNIIRAM).
    Shen J; Bouée S; Aris E; Emery C; Beck EC
    Infect Dis Ther; 2022 Feb; 11(1):249-262. PubMed ID: 34791633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.
    Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL
    Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Invasive meningococcal disease in the Czech Republic - analysis of the epidemiological situation and vaccination strategy recommendations].
    Křížová P; Vacková Z; Musílek M; Kozáková J
    Epidemiol Mikrobiol Imunol; 2013 Dec; 62(4):138-47. PubMed ID: 24467175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Need for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands.
    Bousema JC; Ruitenberg J
    Int J Health Policy Manag; 2015 Sep; 4(11):757-61. PubMed ID: 26673336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive meningococcal disease: Timing and cause of death in England, 2008-2015.
    Beebeejaun K; Parikh SR; Campbell H; Gray S; Borrow R; Ramsay ME; Ladhani SN
    J Infect; 2020 Mar; 80(3):286-290. PubMed ID: 31904388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meningococcal vaccines in France].
    Kernéis S; Coulange-Bodilis H; Launay O
    Rev Prat; 2016 Mar; 66(3):275-279. PubMed ID: 30512637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical diagnoses and outcomes of 4619 hospitalised cases of laboratory-confirmed invasive meningococcal disease in England: Linkage analysis of multiple national databases.
    Edge C; Waight P; Ribeiro S; Borrow R; Ramsay M; Ladhani S
    J Infect; 2016 Nov; 73(5):427-436. PubMed ID: 27475788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
    Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
    Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease.
    Hellenbrand W; Koch J; Harder T; Bogdan C; Heininger U; Tenenbaum T; Terhardt M; Vogel U; Wichmann O; von Kries R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1314-43. PubMed ID: 26487381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations.
    Acevedo R; Bai X; Borrow R; Caugant DA; Carlos J; Ceyhan M; Christensen H; Climent Y; De Wals P; Dinleyici EC; Echaniz-Aviles G; Hakawi A; Kamiya H; Karachaliou A; Lucidarme J; Meiring S; Mironov K; Sáfadi MAP; Shao Z; Smith V; Steffen R; Stenmark B; Taha MK; Trotter C; Vázquez JA; Zhu B
    Expert Rev Vaccines; 2019 Jan; 18(1):15-30. PubMed ID: 30526162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance Database.
    Weil-Olivier C; Taha MK; Emery C; Bouée S; Beck E; Aris E; Loncle-Provot V; Nachbaur G; Pribil C
    Infect Dis Ther; 2021 Sep; 10(3):1607-1623. PubMed ID: 34170505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global estimate of Neisseria meningitidis serogroups proportion in invasive meningococcal disease: A systematic review and meta-analysis.
    Purmohamad A; Abasi E; Azimi T; Hosseini S; Safari H; Nasiri MJ; Imani Fooladi AA
    Microb Pathog; 2019 Sep; 134():103571. PubMed ID: 31163252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal infections among refugees and immigrants: silent threats of past, present and future.
    Dinleyici EC; Borrow R
    Hum Vaccin Immunother; 2020 Nov; 16(11):2781-2786. PubMed ID: 32347773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of Meningococcal Vaccination Among Men Who Have Sex With Men in New York City.
    Simon MS; Weiss D; Geevarughese A; Kratz MM; Cutler B; Gulick RM; Zucker JR; Varma JK; Schackman BR
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):146-54. PubMed ID: 26334735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.